High-temperature superconductor wire and tape compositions for fusion, MRI, and accelerator magnets

The global push toward compact high-field superconducting magnets — driven by private fusion ventures, next-generation MRI platforms, and large-scale particle accelerator upgrades — is creating durable demand for conductor technologies that extend beyond the incumbent niobium-based wires. Niobium-titanium (NbTi) and Nb3Sn are approaching their intrinsic field ceilings; both require cooling well below 10 K and carry cost and infrastructure burdens that make them increasingly unattractive for programs demanding higher field strength or operational temperatures above 20 K. REBCO and YBCO coated conductors have become the performance benchmark for high-temperature superconductor (HTS) tape, but the field is not closed: compositions, architectures, and doping strategies that offer competitive or complementary performance remain commercially relevant, particularly where critical current density, tape fabrication cost, or field isotropy differ from REBCO. This family of compositions addresses three distinct conductor niches under a single wire/tape/coil patent family. The lead composition is Tl2Ba2Ca2Cu3O10 (Tl-2223), a multilayer cuprate with a confirmed critical temperature near 119 K — one of the highest among all experimentally characterized superconductors. The second member, scandium-doped MgB2, targets the intermediate-temperature niche (~40 K class) with a simple binary boride host that can be fabricated in bulk wire form without the vacuum deposition infrastructure REBCO requires. The third, potassium-doped barium iron arsenide (Ba0.63K0.37Fe2As2, "Ba-122"), is an iron-based superconductor with a critical temperature near 39 K and unusually isotropic upper critical field, making it attractive for tape applications where the magnetic field is not aligned with a single crystallographic axis. The portfolio — the catalysts and energy-conversion materials portfolio — files compositions and device-use claims in this family at a moment when fusion magnet programs (both government and private-sector) are issuing specifications for conductor purchases and when MRI manufacturers are evaluating second-source HTS tape suppliers. Licensing or assignment of this family provides a buyer with coverage over specific substituted variants and fabrication architectures that fall outside or alongside the dominant REBCO/YBCO freedom-to-operate space.

Tl-2223 belongs to the thallium-barium-calcium-copper-oxide cuprate family, crystallizing in a tetragonal I4/mmm space group with three CuO2 planes per formula unit — the same structural motif responsible for its exceptional Tc near 119 K. The parent compound is well-characterized experimentally, and the Tc used in this filing derives from that established literature baseline (Allen-Dynes/McMillan parameterization applied against curated database entries). The novelty targeted by this family is not the parent Tl-2223 itself but rather a Re/Pb-co-substituted tape architecture: partial substitution of rhenium and lead on the thallium/barium sites modifies flux-pinning microstructure and reduces the vapor-pressure hazard associated with pure thallium oxide processing, both of which are practical barriers to Tl-2223 commercialization. The claim strategy is therefore built around the specific co-substitution chemistry and the encapsulated tape form factor designed to manage thallium containment, not around Tl-2223 per se. Scandium-doped MgB2 is disclosed as a prophetic target rather than an experimentally reduced-to-practice composition within this filing. The undoped MgB2 host has a well-known Tc near 39 K and is explicitly distinguished as a comparison example. The premise is that Sc substitution on the Mg site could modulate the electronic density of states at the Fermi level in a way that preserves or slightly shifts the Tc while improving flux-pinning or microstructure; however, as the available data honestly reflect, dopants on the Mg site more commonly depress Tc than elevate it, and no electron-phonon coupling (lambda-tensor) calculation has been performed for the Sc-doped variant. The database index value of approximately 41.4 K attached to MgB2:Sc should be read as a ceiling from the curated superconductor screening database, not as an experimentally confirmed result. The Sc-doping range and synthesis route (distinguished from the undoped binary by process specifics) constitute the whitespace that the claim carves out. Ba0.63K0.37Fe2As2 is the most precisely specified composition in the family. At x = 0.37 potassium doping — near the optimally doped point of the Ba(Fe1-xKx)2As2 phase diagram — the critical temperature reaches approximately 39 K. The iron-arsenide family differs from cuprates in having nearly isotropic upper critical fields (Hc2 anisotropy ratio close to unity), which means tape conductors do not need to maintain a particular crystallographic texture relative to the applied field. This is a meaningful engineering distinction from REBCO, where the ab-plane must be kept roughly parallel to the applied field to achieve high critical current density. The filing distinguishes a Bridgman-growth process from a Sn-flux method, and the specific K-doping level of x = 0.37 from variants outside that window. Computational characterization is drawn from the curated superconductor-screening database (entry 0118a); a full DFT phonon calculation (one source accessed) supports structure stability for the parent phase, but the electron-phonon lambda-tensor has not been computed from first principles for this specific stoichiometry. Across all three compositions, the computational validation pipeline has relied on curated literature lambda values and database-indexed Tc estimates rather than on the multi-potential molecular dynamics and phonon consensus workflow applied to less experimentally mature materials in the broader portfolio. This is appropriate: for well-known superconductors like Tl-2223 and Ba-122, the experimental literature is the primary source of truth, and repeating phonon calculations adds modest informational value. The open proof gates are the electron-phonon lambda-tensor computation for MgB2:Sc and measured Tc/Jc on the actual doped or substituted variants as-fabricated. Those measurements would be required to support prosecution and to satisfy a sophisticated buyer's technical diligence.

The addressable market for HTS wire and tape in high-field magnet applications is estimated at $1–3 billion, spanning fusion magnet programs, MRI original equipment manufacturers, and particle accelerator projects. The estimate reflects the combined capital-equipment spend on conductor materials rather than the broader system value of the end products — a distinction that matters when structuring royalty conversations. MRI is the largest and most predictable revenue segment: global MRI installations number in the tens of thousands and the installed base drives ongoing coil and conductor procurement. High-field research MRI (3T and above) and clinical systems exploring 7T for neuroimaging represent the premium tier where HTS conductors compete on total lifecycle cost relative to liquid-helium-cooled Nb3Sn. Fusion is the higher-variance, higher-ceiling segment. Commonwealth Fusion Systems, TAE Technologies, Helion, and government programs like ITER and SPARC have collectively committed billions of dollars in magnet conductor development. REBCO from a handful of qualified suppliers currently dominates this pipeline, but programs are actively seeking second-source qualifications and alternative conductor technologies that reduce single-supplier risk or offer specific performance advantages (lower hysteresis loss, better joint resistance, different field-temperature profiles). Ba-122, in particular, has attracted interest in the fusion community precisely because of its isotropic upper critical field: solenoid and toroidal magnets that see field in multiple orientations benefit from an isotropic conductor without requiring biaxially textured deposition. Royalty logic for this family would most naturally be a per-meter or per-kilogram rate on tape production under license, rather than a share of system value. Tape producers licensing the specific Re/Pb-co-substituted Tl-2223 architecture or the x = 0.37 Ba-122 Bridgman process would pay on conductor output. A flat license or milestone-plus-royalty structure tied to qualification by a named fusion program or MRI OEM is the alternative, and aligns incentive with actual commercial traction. The prophetic MgB2:Sc claim has narrower near-term royalty potential and would more likely be bundled into a broader license rather than licensed as a standalone asset.

high-field magnet conductor for fusion/MRI; thallium-containment + isotropic-tape strategies

Re/Pb-co-substituted Tl-2223 tape architecture; specific Sc-doping range/process; x=0.37 K-doping + Bridgman-vs-Sn-flux distinction

The most directly motivated buyers are companies and programs already active in HTS conductor development or procurement. This includes the major REBCO tape manufacturers who might want defensive coverage in adjacent compositional spaces, particularly around thallium-cuprate and iron-arsenide conductors where their own estates may be thinner. Fusion magnet developers — particularly those with active conductor qualification programs — could value ownership of Ba-122 Bridgman-process claims as they evaluate isotropic conductor options alongside REBCO. MRI coil manufacturers and their conductor suppliers represent a lower-urgency but steadier licensing opportunity, given that the MRI market procures conductor continuously and second-source qualification drives incremental licensing demand. Government-adjacent research consortia and national laboratory programs with superconductor mandates (such as the U.S. Department of Energy's Magnet Development Program or equivalent European and Japanese programs) are potential licensees for research use, though commercialization typically flows through industrial partners. A strategic acquirer most likely comes from the materials or specialty wire space — American Superconductor, Bruker EAS, SuNAM, Fujikura, or a fusion-focused materials company seeking to build out IP in conductor technology. The bundle value of this family is highest when packaged alongside other superconductor or high-field magnet IP from the portfolio, creating a broader defensive or offensive position that individual composition claims alone cannot achieve.

The principal technical risk is the prophetic status of MgB2:Sc: if scandium doping consistently depresses Tc below the undoped MgB2 baseline, that sub-family has limited commercial value and the claim may face written-description or enablement challenges without experimental reduction to practice. This is an honest limitation acknowledged in the asset description, and a buyer should price that uncertainty into any valuation of the MgB2 portion of the family. The Tl-2223 commercialization risk is real and historical: thallium toxicity has stalled this compound despite its exceptional Tc for decades, and the Re/Pb-containment architecture needs laboratory validation to demonstrate that it actually resolves the processing hazard at manufacturing scale. Ba-122 is the most experimentally grounded of the three in terms of Tc certainty, but Jc in tape form at high fields has been the limiting factor for iron-based superconductors, and a buyer would want to see measured Jc data on the specific Bridgman-processed conductor before committing to development. The FTO risk is non-trivial given the density of the existing HTS patent landscape. The narrow whitespace characterization is accurate, and a full FTO opinion prior to commercial manufacture is a required step. The roadmap to de-risking is straightforward in principle: electron-phonon coupling calculation for MgB2:Sc, then bench-scale synthesis and transport characterization for all three compositions, followed by formal FTO clearance focused on the specific chemistries and processes claimed. Completing those three steps would substantially close the open validation gates and position the family for credible licensing conversations with industrial partners.